Juvenile Dermatomyositis: Advances in Basic Research, Translational Studies and Clinical care
This symposium, co-hosted by Duke University and Cure JM Foundation on March 12, 2022, provides important information on Juvenile Myositis research.
Juvenile Dermatomyositis: Advances in Basic Research, Translational Studies and Clinical care
This symposium, co-hosted by Duke University and Cure JM Foundation on March 12, 2022, provides important information on Juvenile Myositis research.

Watch this recorded Town Hall to learn more about juvenile myositis diagnosis and treatment. In this session, Dr. Stacey Tarvin shares insights into best practice

We expected to hear promising news about the potential for CAR-T therapy to treat myositis at the Global Conference on Myositis (GCOM).
What we heard was more than promising—it was astounding.
What if I told you that there was a therapy that would “reset” the immune system—virtually eliminating the autoimmune response in myositis that causes inflammation, pain, muscle weakness, and other JM conditions of which we are all too familiar.

Cure JM recently hosted its Mental Health Summit, bringing together experts in pediatric anxiety and rheumatology to focus on integrating mental health support into care
Membership is free and we’ll connect you with a network of support, encouragement, and resources.
To have your fundraiser matched, add “DIY Match” in the memo of your online gift or check.